Current treatment options in smoking cessation.

Hospital practice (1995)

Volumn 38, Issue 1, 2010, Pages 53-61

  Crain, Dominique ^a   Bhat, Abid ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZAZEPINE DERIVATIVE; CLONIDINE; NICOTINE; NICOTINE QBETA VACCINE; NICOTINIC AGENT; NORTRIPTYLINE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE; RIMONABANT; VACCINE; VARENICLINE;

ARTICLE; BEHAVIOR THERAPY; COUNSELING; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRACTICE GUIDELINE; SELF HELP; SMOKING CESSATION; TOBACCO DEPENDENCE; UNITED STATES;

ADRENERGIC ALPHA-AGONISTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; BENZAZEPINES; BUPROPION; CLONIDINE; COMBINED MODALITY THERAPY; COUNSELING; HUMANS; NICOTINE; NICOTINIC AGONISTS; NORTRIPTYLINE; PATIENT SELECTION; PIPERIDINES; PRACTICE GUIDELINES AS TOPIC; PYRAZOLES; QUINOXALINES; SELF-HELP GROUPS; SMOKING CESSATION; TOBACCO USE DISORDER; UNITED STATES; VACCINES;

EID: 77953029730     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2010.02.279     Document Type: Article

References (0)